Differences in methylation profiles between long-term survivors and short-term survivors of IDH- wildtype glioblastoma

Abstract Background Patients with glioblastoma (GBM) have a median overall survival (OS) of approximately 16 months. However, approximately 5% of patients survive >5 years. This study examines the differences in methylation profiles between long-term survivors (>5 years, LTS) a...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Matthijs van der Meulen, Ronald Ramos, Mathew Voisin, Vikas Patil, Qingxia Wei, Olivia Singh, Seth Climans, Navya Kalidindi, Rosemarylin Or, Ken Aldape, Phedias Diamandis, David G. Muñoz, Gelareh Zadeh, Warren Mason
Hōputu: Artigo
Reo:Ingarihi
I whakaputaina: 2024
Urunga tuihono:https://doi.org/10.1093/noajnl/vdae001
https://academic.oup.com/noa/advance-article-pdf/doi/10.1093/noajnl/vdae001/55536889/vdae001.pdf
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!